Recently published Necrotizing Enterocolitis Market Insights report includes a comprehensive understanding of current treatment practices, necrotizing enterocolitis emerging drugs, market share of ...

Necrotizing enterocolitis (NEC), the most common infantile gastrointestinal emergency, is one of the most challenging conditions encountered by pediatric surgeons. It occurs in up to 3 in every 1000 ...

Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease occurring in 1% to 5% of all neonatal intensive care unit (NICU) admissions. Although the majority of infants diagnosed with ...

Melbourne researchers have published a breakthrough study that will accelerate new treatments for an often-fatal disease affecting premature babies in intensive care, called necrotising enterocolitis ...

The editors and current author would like to thank and acknowledge the significant contribution of the previous author of this chapter from the 2004 first edition, Dr. Kelly S. Yamasato. This current ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA – Treatment with Entyvio for immunotherapy-induced enterocolitis demonstrated favorable outcomes ...

Chimeric antigen receptor T cell therapy has redefined the treatment of multiple myeloma, offering deep and durable remissions to patients whose disease had resisted every conventional option. Yet a ...

Please provide your email address to receive an email when new articles are posted on . Early recognition and prompt administration of antibiotics are important factors in managing neutropenic ...

In a new study, patients with intestinal inflammatory disease who received immune checkpoint inhibitor (ICI) therapy appeared to have increased risk of ...

NEC may occur in the premature infant as early as the first few days of life to as late as several months of age. [4,16,17] The clinical spectrum varies dramatically from nonspecific symptoms of ...